Vertex to Present at Deutsche Bank BioFEST on December 2
November 20 2014 - 4:01PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that management will participate in a fireside chat at
the Deutsche Bank BioFEST in Boston on December 2 at 8:45 a.m.
ET.
Management’s remarks can be accessed live through Vertex’s
website at www.vrtx.com in the “Investors” section under the
“Events and Presentations” link. To ensure a timely connection, it
is recommended that users register at least 10 minutes prior to the
scheduled webcasts. A replay of the webcasts will also be archived
on the company’s website for a period of two weeks following the
event.
About Vertex
Vertex is a global biotechnology company that aims to discover,
develop and commercialize innovative medicines so people with
serious diseases can lead better lives. In addition to our clinical
development programs focused on cystic fibrosis, Vertex has more
than a dozen ongoing research programs aimed at other serious and
life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research
and development sites and commercial offices in the United States,
Europe, Canada and Australia. For five years in a row, Science
magazine has named Vertex one of its Top Employers in the life
sciences. For additional information and the latest updates from
the company, please visit www.vrtx.com.
(VRTX-WEB)
Vertex Pharmaceuticals
IncorporatedInvestors:Michael Partridge,
617-341-6108orKelly Lewis, 617-961-7530
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024